Innovative Diagnostic Tools EpiFinder is developing a proprietary screening software aimed at neurologists to improve epilepsy diagnosis accuracy and speed at the point of care, representing a compelling opportunity for partnerships with hospitals and specialized clinics seeking advanced diagnostic solutions.
Recognized Industry Leadership The company's receipt of multiple Silver Stevie® Awards and a $1M funding boost in 2018 position EpiFinder as a recognized innovator with credibility in healthcare technology, making it attractive to investors and strategic partners interested in cutting-edge health tech.
Growing Market Presence With a revenue range of $10M to $25M and notable competitors like BrainCheck and Linus Health, EpiFinder indicates a strong foothold in the neurological health sector, offering potential for collaborative expansion into clinical networks and healthcare providers.
Educational and Research Momentum The company's university-based internship program highlights engagement with academic institutions and a focus on research and development, creating opportunities for research collaborations, pilot programs, or joint innovation initiatives.
Emerging Digital Solutions The recent launch of a patient portal app positions EpiFinder as a provider of digital health management tools, opening avenues to sell integrated electronic patient engagement platforms to hospitals and outpatient clinics aiming to improve patient experience.